• |
  • |
  • |
  • |
Donate

Product

LEND: Prevalence and risk factors for cisplatin induced hearing loss in children and adolescents: a multi-institutional North American cohort study

Center:
Fiscal Year:
2021
Contact Information:
Product Description:
Large multi-institution study designed to determine the prevalence of severe hearing loss associated with cisplatin chemotherapy and identify patient- and treatment-related risk factors.
Keyword(s):
hearing loss, cisplatin, ototoxicity, children, cancer
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals submitted
Target Audience:
Professionals, Students
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A